Healthcare & Medical Devices Global On demand · 24-48h

Global Veterinary IV Catheters Market Strategic Research Report

Global Veterinary IV Catheters Market Strategic Research Rep…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Veterinary IV Catheters Market
$4982025
5.5%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Peripheral Intravenous Catheters, Central Venous Catheters, Others

By Application: Pets and Small Animals, Large Animals

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: B. Braun Vet Care, Becton Dickinson, ICU Medical, Covetrus, MWI Animal Health, Jorgensen Laboratories, Terumo Medical, Shanghai Kindly Group, Vygon Vets, Millpledge, Cardinal Health, Mila International, Génia, Jiangsu Caina Medical

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 117 pages
Market size 2025
$498
Million USD
Forecast CAGR
5.5%
2025-2032
Forecast 2032
$724.4
Projected
Regiones
5
Asia Pacific · Latin America · MEA · Europe · North America

Vista general

Scope of the Report

The global Veterinary IV Catheters market size is predicted to grow from US$ 498 million in 2025 to US$ 719 million in 2032; it is expected to grow at a CAGR of 5.5% from 2026 to 2032.

Veterinary IV catheters are medical devices designed for the administration of intravenous fluids or medications in animals. Similar to those used in human medicine, these catheters consist of a flexible tube that is inserted into a vein, typically through a needle, allowing for the direct delivery of fluids into the circulatory system. Veterinary IV catheters play a crucial role in various clinical settings, such as surgeries, emergencies, or routine medical care, providing veterinarians with a safe and efficient means of administering fluids to support hydration, deliver medications, or facilitate blood collection in animals.

The veterinary IV catheters market is growing steadily as the demand for advanced veterinary care rises, driven by increasing pet ownership, the expanding livestock industry, and the growing awareness of animal health.

With more animals requiring medical attention, especially in critical care and surgical procedures, IV catheters play a crucial role in providing hydration, medications, and nutrition. The market is also being shaped by innovations in catheter technology, such as improvements in material to reduce infection risks, ease of insertion, and patient comfort. Additionally, the trend toward high-quality, disposable, and needle-free products is expected to continue gaining traction as veterinary practices prioritize safety and hygiene.

As veterinary medicine continues to advance, the market for IV catheters is likely to see continued growth, particularly with the increasing integration of veterinary care in both developed and emerging markets.

However, market growth may be challenged by cost considerations, especially for smaller practices, and the need for high-quality, reliable products in increasingly competitive markets.

This report presents a comprehensive overview of the global Veterinary IV Catheters market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Peripheral Intravenous Catheters
  • Central Venous Catheters
  • Others

Segment by Application

  • Pets and Small Animals
  • Large Animals

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Veterinary IV Catheters market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Pets and Small Animals, Large Animals evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Veterinary IV Catheters Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.5%
Regional growth momentum
Market share by segment
Key metrics
Base value
$498
2025
Forecast
$724.4
2032
CAGR
5.5%
2025–2032
Regiones
5
global
Key companies
B. Braun Vet CareBecton DickinsonICU MedicalCovetrusMWI Animal HealthJorgensen LaboratoriesTerumo MedicalShanghai Kindly Group
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Peripheral Intravenous CathetersCentral Venous CathetersOthers
By Application
Pets and Small AnimalsLarge Animals

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Peripheral Intravenous Catheters
  • 3.1.3 Central Venous Catheters
  • 3.1.4 Others
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Pets and Small Animals
  • 4.1.3 Large Animals
  • 4.1.4 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 B. Braun Vet Care
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Becton Dickinson
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 ICU Medical
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Covetrus
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 MWI Animal Health
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Jorgensen Laboratories
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Terumo Medical
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Shanghai Kindly Group
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Vygon Vets
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Millpledge
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Cardinal Health
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Mila International
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Génia
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Jiangsu Caina Medical
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Veterinary IV Catheters market?
The global Veterinary IV Catheters market is estimated at US$ 498 million in 2025 (base year) and is projected to reach US$ 719 million by 2032.
What is the forecast CAGR for the Veterinary IV Catheters market?
The market is expected to grow at a CAGR of 5.5% from 2026 to 2032, expanding from US$ 498 million in 2025 to US$ 719 million in 2032, roughly 1.4 times its base-year value.
What is Veterinary IV Catheters?
Veterinary IV catheters are medical devices designed for the administration of intravenous fluids or medications in animals. Similar to those used in human medicine, these catheters consist of a flexible tube that is inserted into a vein, typically through a needle, allowing for the direct delivery of fluids into the circulatory system.
What are the main segments of the Veterinary IV Catheters market by type?
By type, the market is segmented into Peripheral Intravenous Catheters, Central Venous Catheters and Others.
Which applications drive demand in the Veterinary IV Catheters market?
Key applications covered include Pets and Small Animals and Large Animals.
Who are the key players in the Veterinary IV Catheters market?
Key players profiled include B. Braun Vet Care, Becton Dickinson, ICU Medical, Covetrus, MWI Animal Health, Jorgensen Laboratories, Terumo Medical and Shanghai Kindly Group, among 14 companies covered in total.
Which regions and countries are covered for Veterinary IV Catheters?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Veterinary IV Catheters market?
The veterinary IV catheters market is growing steadily as the demand for advanced veterinary care rises, driven by increasing pet ownership, the expanding livestock industry, and the growing awareness of animal health.
Who should buy the Veterinary IV Catheters market report?
The report is intended for manufacturers and solution providers, distributors and end users in Pets and Small Animals and Large Animals, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Veterinary IV Catheters market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3.500,00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.